12,13 Modifications to prolong the half-life of GLP-1 RAs include sequence substitutions conferring resistance to DPP-4, along with acylation (liraglutide and semaglutide), covalent bonding to modified Ig fragment crystallisable domain (dulaglutide), or covalent bonding to albumin
- & The GLP-1 agonist market is rapidly evolving, with leading pharmaceutical companies like Novo Nordisk, Eli Lilly, and Sanofi at the forefront of innovation
PMID: 78 NCT06475586
Prevention of glutathione depletion with N-acetylcysteine or glutathione esters abrogates TGF--stimulated collagen production, while deliberate glutathione depletion enhances collagen synthesis
Anyone considering ipamorelin should discuss it with a clinician who knows their personal medical history, their cardiovascular risk, their metabolic baseline, and any concurrent medications